1. | Introduction | 1 |
| Some Definitions | 2 |
| The Problem of Drug Abuse | 6 |
| Patterns and Development of Drug Use | 8 |
| Predictors of Initiation of Drug Abuse | 9 |
| Correlates of Cessation of Drug Use | 11 |
| Neurological Aspects of Drug Abuse | 12 |
2. | Tobacco and Nicotine | 17 |
| Tobacco Culture | 17 |
| Epidemiology and Patterns of Use | 19 |
| Pharmacokinetics and Pharmacodynamics | 22 |
| Effects of Nicotine | 23 |
| Subjective Effects | 23 |
| Physiological Dependence and Tolerance | 24 |
| Physiological Effects | 24 |
| Mechanism of Central Action | 26 |
| Morbidity and Mortality | 27 |
| Coronary Heart Disease | 27 |
| Cancer | 28 |
| Chronic Obstructive Pulmonary Disease | 29 |
| Smoking and Fetal Development | 29 |
| Passive Smoking | 29 |
| Treatment of Nicotine Addiction | 31 |
3. | Opioids | 35 |
| Culture and History | 35 |
| Opioid Drugs | 39 |
| Patterns of Use | 42 |
| Effects of Opioid Drugs | 44 |
| Subjective Effects | 44 |
| Analgesia | 45 |
| Gastrointestinal System | 45 |
| Respiration | 46 |
| In Utero Effects | 46 |
| Physiological Dependence | 47 |
| Tolerance | 48 |
| Mechanism of Action | 48 |
| Absorption and Fate | 49 |
| Toxicity | 50 |
| Pharmacological Treatment of Abuse | 51 |
4. | Depressants of the Central Nervous System: Alcohol, Barbiturates, and Benzodiazepines | 55 |
| Alcohol | 56 |
| Epidemiology and Patterns of Use | 56 |
| Genetics and Alcoholism | 58 |
| Central Nervous System Effects of Alcohol | 59 |
| Absorption, Distribution, and Metabolism | 64 |
| In Utero Effects of Alcohol | 66 |
| Beneficial Effects of Alcohol | 67 |
| Morbidity | 67 |
| Mortality | 71 |
| Pharmacological Treatment of Alcholism | 72 |
| Barbiturate and Nonbarbiturate Sedative-Hypnotics | 73 |
| Benzodiazepines and other Minor Tranquilizers | 73 |
| Effects of Benzodiazepines | 73 |
| Patterns of Use | 74 |
| Mechanism of Action | 75 |
| Tolerance and Physiological Dependence | 76 |
| Other Minor Tranquilizers | 77 |
5. | Depressants of the Central Nervous System: Volatile Solvents and Aerosols | 81 |
| Preparation Used | 83 |
| Patterns of Use | 84 |
| Effects of Volatile Solvents | 86 |
| Habitual Use of Volatile Solvents | 87 |
| Physiological Dependence | 87 |
| Toxic Effects of Volatile Solvents: Morbidity and Mortality | 87 |
| Aliphatic Hydrocarbons | 88 |
| Aromatic Hydrocarbons | 88 |
| Halogenated Hydrocarbons (Alkyl Halides) | 89 |
| Ketones | 90 |
| Esters | 90 |
| Nitrites | 90 |
6. | Club Drugs: Methylenedioxymethamphetamine (MDMA), Gamma Hydroxybutyrate (GHB), Ketamine, and Agents Taken in Similar Patterns | 94 |
| Methylenedioxymethamphetamine | 95 |
| Chemistry and Mechanism of Action | 95 |
| Effects and Toxicity | 96 |
| Patterns of Use | 97 |
| Metabolism | 97 |
| Gamma Hydroxybutyrate | 97 |
| Effects and Phamacokinetics | 98 |
| Dependence and Withdrawal | 99 |
| Medical Indications | 99 |
| Hallucinogens | 99 |
| Ketamine and Phencyclidine | 100 |
| Lysergic Acid Diethylamide | 104 |
7. | Marijuana and Hashish | 108 |
| Epidemiology and Patterns of Use | 109 |
| Pharmacokinetics and Pharmacodynamics | 110 |
| Physiological Dependence and Tolerance | 112 |
| Effects of Marijuana | 113 |
| Subjective Effects | 113 |
| Physiological Effects | 115 |
| Mechanism of Central Action | 116 |
| Adverse Effects | 117 |
| Acute Adverse Effects | 117 |
| Persistent Adverse Effects | 118 |
| Medical Use | 119 |
8. | Central Nervous System Stimulants: Cocaine, Amphetamines, Related Drugs, and Caffeine | 123 |
| Cocaine | 124 |
| Mechanism of Action, Absorption, and Fate | 126 |
| Toxicity | 127 |
| The Amphetamines | 128 |
| Neurotoxicity | 131 |
| Mechanism of Action, Absorption, and Fate | 131 |
| Effects of Amphetamine and Cocaine | 131 |
| Patterns of Use | 132 |
| Physiological Dependence on Stimulants | 134 |
| Khat Chewing and Cathinone | 134 |
| Caffeine and Theophylline | 135 |
| Patterns of Use | 136 |
| Effects | 136 |
| Physiological Dependence | 137 |
| Drugs Used to Treat Hyperactivity and Obesity | 139 |
9. | Medical Issues Associated with Drug Abuse | 142 |
| Infections Resulting from Intravenous Drug Use | 142 |
| Heart | 143 |
| Lung | 144 |
| Central Nervous System | 144 |
| Liver | 145 |
| Skin and Soft Tissue | 146 |
| Bone and Joint | 148 |
| Immune System | 148 |
| Pulmonary Health Risks from Smoking Illicit Drugs | 150 |
| Marijuana | 150 |
| Cocaine | 151 |
10. | Drug Abuse and the Law | 154 |
| Drug Abuse and American Federal Law | 154 |
| Drug Abuse and International Law | 165 |
| Index | 171 |